165 related articles for article (PubMed ID: 27799071)
1. Evaluation of ColdZyme® Mouth Spray on prevention of upper respiratory tract infections in a boy with primary immunodeficiency: a case report.
Clarsund M; Blom U; Gardulf A
J Med Case Rep; 2016 Oct; 10(1):302. PubMed ID: 27799071
[TBL] [Abstract][Full Text] [Related]
2. Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.
Lindberg BF; Nelson I; Ranstam J; Riker DK
PLoS One; 2023; 18(1):e0279204. PubMed ID: 36652464
[TBL] [Abstract][Full Text] [Related]
3. Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
Davison G; Perkins E; Jones AW; Swart GM; Jenkins AR; Robinson H; Dargan K
Eur J Sport Sci; 2021 May; 21(5):771-780. PubMed ID: 32419645
[TBL] [Abstract][Full Text] [Related]
4. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
[TBL] [Abstract][Full Text] [Related]
5. ColdZyme® protects airway epithelia from infection with BA.4/5.
Zaderer V; Dichtl S; Bellmann Weiler R; Lass Flörl C; Posch W; Wilflingseder D
Respir Res; 2022 Oct; 23(1):300. PubMed ID: 36316674
[TBL] [Abstract][Full Text] [Related]
6. Does Trypsin Oral Spray (Viruprotect
Huijghebaert S; Vanham G; Van Winckel M; Allegaert K
Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064793
[TBL] [Abstract][Full Text] [Related]
7. Infections in 252 patients with common variable immunodeficiency.
Oksenhendler E; Gérard L; Fieschi C; Malphettes M; Mouillot G; Jaussaud R; Viallard JF; Gardembas M; Galicier L; Schleinitz N; Suarez F; Soulas-Sprauel P; Hachulla E; Jaccard A; Gardeur A; Théodorou I; Rabian C; Debré P;
Clin Infect Dis; 2008 May; 46(10):1547-54. PubMed ID: 18419489
[TBL] [Abstract][Full Text] [Related]
8. Observational study on the performance of the Narhinel method (nasal aspirator and physiological saline solution) versus physiological saline solution in the prevention of recurrences of viral rhinitis and associated complications of the upper respiratory tract infections (URTI), with a special focus on acute rhinosinusitis and acute otitis of the middle ear.
Montanari G; Ceschin F; Masotti S; Bravi F; Chinea B; Quartarone G
Minerva Pediatr; 2010 Feb; 62(1):9-16, 17-21. PubMed ID: 20212394
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.
Favre O; Leimgruber A; Nicole A; Spertini F
Allergy; 2005 Mar; 60(3):385-90. PubMed ID: 15679727
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease.
Arora R; Newton TC; Nelson MR
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):367-70. PubMed ID: 17941286
[TBL] [Abstract][Full Text] [Related]
11. Common variable immunodeficiency in an adult with recurrent pneumonia.
Kart L; Tor M; Altin R; Tekin IO; Sayarlůoglu H; Ustundag Y; Gun BD
Monaldi Arch Chest Dis; 2003; 59(1):84-7. PubMed ID: 14533287
[TBL] [Abstract][Full Text] [Related]
12. Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy.
Shapiro RS
Immunotherapy; 2012 Dec; 4(12):1835-9. PubMed ID: 23240751
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
Baris S; Ercan H; Cagan HH; Ozen A; Karakoc-Aydiner E; Ozdemir C; Bahceciler NN
J Investig Allergol Clin Immunol; 2011; 21(7):514-21. PubMed ID: 22312934
[TBL] [Abstract][Full Text] [Related]
14. [Recurrent respiratory tract infections].
Heidgen FJ; Ko YD; Fronhoffs S; Vetter H
Praxis (Bern 1994); 1995 Sep; 84(39):1079-82. PubMed ID: 7481311
[TBL] [Abstract][Full Text] [Related]
15. Resolution of warts in association with subcutaneous immunoglobulin in immune deficiency.
Lin JH; Wang KY; Kraft S; Roberts RL
Pediatr Dermatol; 2009; 26(2):155-8. PubMed ID: 19419461
[TBL] [Abstract][Full Text] [Related]
16. Clinical picture and treatment of 2212 patients with common variable immunodeficiency.
Gathmann B; Mahlaoui N; ; Gérard L; Oksenhendler E; Warnatz K; Schulze I; Kindle G; Kuijpers TW; ; van Beem RT; Guzman D; Workman S; Soler-Palacín P; De Gracia J; Witte T; Schmidt RE; Litzman J; Hlavackova E; Thon V; Borte M; Borte S; Kumararatne D; Feighery C; Longhurst H; Helbert M; Szaflarska A; Sediva A; Belohradsky BH; Jones A; Baumann U; Meyts I; Kutukculer N; Wågström P; Galal NM; Roesler J; Farmaki E; Zinovieva N; Ciznar P; Papadopoulou-Alataki E; Bienemann K; Velbri S; Panahloo Z; Grimbacher B;
J Allergy Clin Immunol; 2014 Jul; 134(1):116-26. PubMed ID: 24582312
[TBL] [Abstract][Full Text] [Related]
17. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency.
Lin JH; Liebhaber M; Roberts RL; Dyer Z; Stiehm ER
J Allergy Clin Immunol; 2006 Apr; 117(4):878-82. PubMed ID: 16630948
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
[TBL] [Abstract][Full Text] [Related]
19. Respiratory disorders in common variable immunodeficiency.
Martínez García MA; de Rojas MD; Nauffal Manzur MD; Muñoz Pamplona MP; Compte Torrero L; Macián V; Perpiñá Tordera M
Respir Med; 2001 Mar; 95(3):191-5. PubMed ID: 11266236
[TBL] [Abstract][Full Text] [Related]
20. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis.
Onbaşi K; Günşar F; Sin AZ; Ardeniz O; Kokuludağ A; Sebik F
Turk J Gastroenterol; 2005 Jun; 16(2):111-3. PubMed ID: 16252205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
